THREAD
There’s much debate around the UK's recommended use of the AZ vaccine with a two-dose schedule and flexible timing of second dose. Some thoughts on the AZ recommendation (not Pfizer) based on available data with refs to some excellent threads.

UK’s MHRA and JCVI are highly-experienced in vaccine assessments and recommendations, and they've surely weighed the benefits & risks of this recommendation carefully. That said, it would be good to see all the data underpinning their recommendation. 2/
https://t.co/NRcHbYxRIw
In general, vaccines should be taken on a schedule tested in an efficacy trial. But it wasn’t possible to conduct the typical dose and schedule optimization prior to these Ph3 trials, and those trials provided valuable data to inform these recommendations. 3/
The UK recommends a two-dose schedule, with the second dose between 4-12 weeks. This *is not* a single dose schedule. Given the data provided, and in the setting of limited supply, overstretched hospitals, and emergence of a more transmissible variant, this seems justifiable. 4/
The UK has important data on the AZ Vx that wasn’t available for Pfizer & Moderna at FDA's VRBPAC, including:
* single-dose efficacy through 4+ months; and
* single-dose immunogenicity (12+ weeks). 5/
https://t.co/vtbviE9VEx
The data shows the AZ vaccine maintains efficacy in the setting of a delayed second dose, although it’s not clear how fast this wanes over time. Delay of the second dose provides a better booster effect as measured by antibody levels, which is seen with other vaccines. 6/
The second dose is important because it can drive a more robust and higher quality antibody response through a process called affinity maturation. It's well-understood that longer intervals can provide a better boost. 7/ https://t.co/cqKIpomUHg
In my view, the immediate priority is prevention of severe disease that drives deaths and the strain on health systems. Efficacy against severe disease is likely better than overall vaccine efficacy. Data after the first dose is promising although the numbers are small. 8/
There’s nothing magic about the (short) 28d interval between doses, which was presumably chosen to ensure rapid onset of protection in Ph3. Vaccine efficacy won't disappear overnight with a delayed 2nd dose - it will wane over time, if at all. Ph3 data supports that concept. 9/
Yes there are risks of waning immunity, non-compliance with the second dose, confusion among the public, etc. Many are implementation considerations that can be addressed with planning and strong communication. 10/
It will be critically important to collect efficacy data around this “flexible second dose” schedule, esp in older adults & against severe disease, to inform licensure and recommendations in countries around the world that are counting on the introduction of this vaccine. 11/
Yes the AZ/Oxford studies had a number of issues, but we must remember that this highly-complex development program was executed in less than a year. And that Pfizer & Moderna's Ph3 execution & vaccine efficacy created very high expectations for all subsequent programs. 12/
The bottom line is that every country needs to make difficult policy decisions with the data they have, not what they'd like to have. There's no perfect answer here, but now that a decision has been taken, the UK can focus on maximizing the benefit and mitigating any risks. 13/

More from Government

1.
Act of 1871
This is VERY Long but it will end with a MEGA BOOM!
Bookmark it and read it in small bits to digest it all.

This info, comes from some reputable anons and my own digging, compiled together as a superthread!
InevitableET, IPOT... to name a few.

2.
https://t.co/udep5WEYUp
https://t.co/bnzeQek6zv


3.
The TL; DR version is they, by military force, and illegitimate legislature, amended the constitution against the will of The People and legally tricked us into becoming unwitting indentured slaves of human capital and resources to THE UNITED STATES OF AMERICA the corporation)

4.
Republic vs Democracy
-They needed to get away from the Republic and create a Democracy in order to drive us towards socialism and inevitably a dictatorship (National Socialist Party aka NAZI)


5.
Flag
Which metric is a better predictor of the severity of the fall surge in US states?

1) Margin of Democrat victory in Nov 2020 election
or
2) % infected through Sep 1, 2020

Can you guess which plot is which?


The left plot is based on the % infected through Sep 1, 2020. You can see that there is very little correlation with the % infected since Sep 1.

However, there is a *strong* correlation when using the margin of Biden's victory (right).

Infections % from
https://t.co/WcXlfxv3Ah.


This is the strongest single variable I've seen in being able to explain the severity of this most recent wave in each state.

Not past infections / existing immunity, population density, racial makeup, latitude / weather / humidity, etc.

But political lean.

One can argue that states that lean Democrat are more likely to implement restrictions/mandates.

This is valid, so we test this by using the Government Stringency Index made by @UniofOxford.

We also see a correlation, but it's weaker (R^2=0.36 vs 0.50).

https://t.co/BxBBKwW6ta


To avoid look-ahead bias/confounding variables, here is the same analysis but using 2016 margin of victory as the predictor. Similar results.

This basically says that 2016 election results is a better predictor of the severity of the fall wave than intervention levels in 2020!

You May Also Like

1/“What would need to be true for you to….X”

Why is this the most powerful question you can ask when attempting to reach an agreement with another human being or organization?

A thread, co-written by @deanmbrody:


2/ First, “X” could be lots of things. Examples: What would need to be true for you to

- “Feel it's in our best interest for me to be CMO"
- “Feel that we’re in a good place as a company”
- “Feel that we’re on the same page”
- “Feel that we both got what we wanted from this deal

3/ Normally, we aren’t that direct. Example from startup/VC land:

Founders leave VC meetings thinking that every VC will invest, but they rarely do.

Worse over, the founders don’t know what they need to do in order to be fundable.

4/ So why should you ask the magic Q?

To get clarity.

You want to know where you stand, and what it takes to get what you want in a way that also gets them what they want.

It also holds them (mentally) accountable once the thing they need becomes true.

5/ Staying in the context of soliciting investors, the question is “what would need to be true for you to want to invest (or partner with us on this journey, etc)?”

Multiple responses to this question are likely to deliver a positive result.